Blinatumomab Intravenous and Oxcarbazepine Extended-Release Tablets
Determining the interaction of Blinatumomab Intravenous and Oxcarbazepine Extended-Release Tablets and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: blinatumomab
Brand name: Blincyto
Synonyms: Blinatumomab
Generic Name: oxcarbazepine
Brand name: Oxtellar XR, Trileptal
Synonyms: Oxcarbazepine, OXcarbazepine
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Blinatumomab Intravenous-Oxcarbazepine Oral Suspension
- Blinatumomab Intravenous-Oxcarbazepine Suspension
- Blinatumomab Intravenous-Oxcarbazepine Tablets
- Blinatumomab Intravenous-Oxecta
- Blinatumomab Intravenous-Oxilan
- Blinatumomab Intravenous-Oxipor VHC
- Oxcarbazepine Extended-Release Tablets-Blincyto
- Oxcarbazepine Extended-Release Tablets-Blisovi 24 Fe
- Oxcarbazepine Extended-Release Tablets-Blisovi 24 FE birth control
- Oxcarbazepine Extended-Release Tablets-Blisovi Fe 1.5/30
- Oxcarbazepine Extended-Release Tablets-Blisovi Fe 1/20
- Oxcarbazepine Extended-Release Tablets-Blocadren